I

Inovio Pharmaceuticals

INO

10.000
USD
-0.67
(-6.28%)
Market Open
Volume
6,531
EPS
0
Div Yield
0
P/E
-1
Market Cap
147,736,685
Related Instruments
AZN
2.040
(2.58%)
81.200 USD
B
BNTX
-5.530
(-6.42%)
80.570 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
MRK
0.680
(0.60%)
113.800 USD
MRNA
-25.020
(-20.99%)
94.160 USD
N
NVAX
-0.250
(-1.95%)
12.560 USD
PFE
0.115
(0.38%)
30.650 USD
REGN
13.14
(1.22%)
1,091.19 USD
V
VCEL
-2.900
(-5.72%)
47.800 USD
News

Title: Inovio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.